BCL2 and neuroblastoma: In conclusion, these studies indicate that the antiapoptotic BCL-2 proteins maintain survival of neuroblastoma cells by inhibiting BAK and that treatment with BH3-mimetics released BAK from its antiapoptotic binding partners.